Metal Metabolism: Transport, Development and Neurodegeneration

Wilson’s disease is a severe human disorder of copper homoeostasis. The disease is associated with various mutations in the ATP7B gene that encodes a copper-transporting ATPase, and a massive accumulation of copper in the liver and several other tissues. The most frequent disease manifestations include a wide spectrum of liver pathologies as well as neurological and psychiatric abnormalities. A combination of copper chelators and zinc therapy has been used to prevent disease progression; however, accurate and timely diagnosis of the disease remains challenging. Similarly, side effects of treatments are common. To understand better the biochemical and cellular basis of Wilson’s disease, several animal models have been developed. This review focuses on genetically engineered Atp7b −/− mice and describes the properties of these knockout animals, insights into the disease progression generated using Atp7b −/− mice, as well as advantages and limitations of Atp7b −/− mice as an experimental model for Wilson’s disease.

[1]  H. Karakayalı,et al.  Long term follow‐up of glomerular and tubular functions in liver transplanted patients with Wilson’s disease , 2008, Pediatric transplantation.

[2]  M. Linder,et al.  Copper transport during lactation in transgenic mice expressing the human ATP7A protein. , 2008, Biochemical and biophysical research communications.

[3]  J. Camakaris,et al.  ATP7B Expression in Human Breast Epithelial Cells Is Mediated by Lactational Hormones , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[4]  J. Mercer,et al.  ATP7A transgenic and nontransgenic mice are resistant to high copper exposure. , 2008, The Journal of nutrition.

[5]  D. Cox,et al.  New mutations in the Wilson disease gene, ATP7B: implications for molecular testing. , 2008, Genetic testing.

[6]  S. Lutsenko,et al.  Copper-transporting ATPases ATP7A and ATP7B: cousins, not twins , 2007, Journal of bioenergetics and biomembranes.

[7]  J. Camakaris,et al.  Distinct Functional Roles for the Menkes and Wilson Copper Translocating P-type ATPases in Human Placental Cells , 2007, Cellular Physiology and Biochemistry.

[8]  Y. Gho,et al.  Activation of microglial cells by ceruloplasmin , 2007, Brain Research.

[9]  J. Mercer,et al.  Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis. , 2007, Archives of biochemistry and biophysics.

[10]  Svetlana Lutsenko,et al.  Function and regulation of human copper-transporting ATPases. , 2007, Physiological reviews.

[11]  C. Yurdaydın,et al.  Late-onset Wilson's disease. , 2007, Gastroenterology.

[12]  C. Pfeiffer,et al.  Wilson's disease. , 2007, Archives of neurology.

[13]  O. Fiehn,et al.  High Copper Selectively Alters Lipid Metabolism and Cell Cycle Machinery in the Mouse Model of Wilson Disease* , 2007, Journal of Biological Chemistry.

[14]  J. Camakaris,et al.  Hormonal regulation of the Menkes and Wilson copper-transporting ATPases in human placental Jeg-3 cells. , 2007, The Biochemical journal.

[15]  S. Lutsenko,et al.  Hepatic copper-transporting ATPase ATP7B: function and inactivation at the molecular and cellular level , 2007, BioMetals.

[16]  R. Mains,et al.  Developmental changes in the expression of ATP7A during a critical period in postnatal neurodevelopment , 2006, Neuroscience.

[17]  J. Markley,et al.  Solution structure of the N-domain of Wilson disease protein: distinct nucleotide-binding environment and effects of disease mutations. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Finegold,et al.  Consequences of copper accumulation in the livers of the Atp7b-/- (Wilson disease gene) knockout mice. , 2006, The American journal of pathology.

[19]  L. Braiterman,et al.  NH2-terminal signals in ATP7B Cu-ATPase mediate its Cu-dependent anterograde traffic in polarized hepatic cells. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[20]  S. Lutsenko,et al.  The Copper-transporting ATPases, Menkes and Wilson Disease Proteins, Have Distinct Roles in Adult and Developing Cerebellum* , 2005, Journal of Biological Chemistry.

[21]  Yurij A. Kosinsky,et al.  The Distinct Functional Properties of the Nucleotide-binding Domain of ATP7B, the Human Copper-transporting ATPase* , 2004, Journal of Biological Chemistry.

[22]  Xiao-qing Liu,et al.  Correlation of ATP7B genotype with phenotype in Chinese patients with Wilson disease. , 2004, World journal of gastroenterology.

[23]  H. Ushijima,et al.  Mutation spectrum and polymorphisms in ATP7B identified on direct sequencing of all exons in Chinese Han and Hui ethnic patients with Wilson's disease , 2003, Clinical genetics.

[24]  S. Lutsenko,et al.  A Mutation in the ATP7B Copper Transporter Causes Reduced Dopamine β-Hydroxylase and Norepinephrine in Mouse Adrenal , 2003, Neurochemical Research.

[25]  S. David,et al.  Expression of a membrane‐bound form of the ferroxidase ceruloplasmin by leptomeningeal cells , 2003, Glia.

[26]  V. Coronado,et al.  The Jackson toxic milk mouse as a model for copper loading , 2001, Mammalian Genome.

[27]  M. Caggana,et al.  Estimate of the frequency of Wilson's disease in the US Caucasian population: a mutation analysis approach. , 2001, Annals of human genetics.

[28]  R. Vonk,et al.  Copper-induced apical trafficking of ATP7B in polarized hepatoma cells provides a mechanism for biliary copper excretion. , 2000, Gastroenterology.

[29]  A. Angius,et al.  Molecular characterization of Wilson disease in the Sardinian population—Evidence of a founder effect , 1999, Human mutation.

[30]  T. Gilliam,et al.  Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation. , 1999, Human molecular genetics.

[31]  T. Sugiyama,et al.  The Long–Evans Cinnamon rat: An animal model for Wilson’s disease , 1999, Pediatrics international : official journal of the Japan Pediatric Society.

[32]  S. Snyder,et al.  A Novel Pineal Night-Specific ATPase Encoded by the Wilson Disease Gene , 1999, The Journal of Neuroscience.

[33]  D. Cox,et al.  Functional characterization of missense mutations in ATP7B: Wilson disease mutation or normal variant? , 1998, American journal of human genetics.

[34]  D W Cox,et al.  The toxic milk mouse is a murine model of Wilson disease. , 1996, Human molecular genetics.

[35]  J. Gitlin,et al.  Ceruloplasmin gene expression in the murine central nervous system. , 1996, The Journal of clinical investigation.

[36]  J. Peppercorn,et al.  The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene , 1993, Nature Genetics.

[37]  J. Rommens,et al.  The Wilson disease gene is a putative copper transporting P–type ATPase similar to the Menkes gene , 1993, Nature Genetics.

[38]  P. Kuan.  Cardiac Wilson's disease. , 1987, Chest.

[39]  M. Linder,et al.  Distribution of copper among components of human serum. , 1985, Journal of the National Cancer Institute.

[40]  J. Re,et al.  Wilson's disease. Electron microscopic, x-ray energy spectroscopic, and atomic absorption spectroscopic studies of corneal copper deposition and distribution. , 1982 .

[41]  J. Kaplan,et al.  Intracellular targeting of copper-transporting ATPase ATP7A in a normal and Atp7b-/- kidney. , 2008, American journal of physiology. Renal physiology.

[42]  B. Thapa,et al.  Analysis of most common mutations R778G, R778L, R778W, I1102T and H1069Q in Indian Wilson disease patients: Correlation between genotype/phenotype/copper ATPase activity , 2005, Molecular and Cellular Biochemistry.

[43]  G. Brewer.  Neurologically Presenting Wilson’s Disease , 2005, CNS drugs.

[44]  S. Factor,et al.  The cardiomyopathy of Wilson's disease , 2004, Virchows Archiv A.